Cardioprotective interventions for cancer patients receiving anthracyclines

BACKGROUND: Anthracyclines are among the most effective chemotherapeutic agents in the treatment of numerous malignancies. Unfortunately, their use is limited by a dose‐dependent cardiotoxicity. In an effort to prevent this cardiotoxicity, different cardioprotective agents have been studied. OBJECTI...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cochrane Database Syst Rev
Main Authors: van Dalen, Elvira C, Caron, Huib N, Dickinson, Heather O, Kremer, Leontien CM
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2011
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6457676/
https://ncbi.nlm.nih.gov/pubmed/21678342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003917.pub4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki